Literature DB >> 10547586

Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin.

S A Cotton1, A L Herrick, M I Jayson, A J Freemont.   

Abstract

Although a multisystem disease, systemic sclerosis (SSc) most commonly affects the skin. The skin lesion is characterized by progressive changes, chief amongst which are vascular abnormalities, including endothelial cell (EC) injury and death, and dermal fibrosis. The pathogenesis of the vascular changes, and their relationship to dermal fibrosis, is poorly understood. The purpose of this study was to examine the potential role of nitric oxide (NO)-related free radical production, as part of an assessment of mechanisms leading to endothelial damage. Histologically graded skin biopsies from 33 patients with SSc (ten grade 0, ten grade 1, eight grade 2, and five grade 3) and eight healthy controls were reacted with antibodies against constitutive (eNOS) and inducible (iNOS) forms of nitric oxide synthase and nitrotyrosine. The degree of staining was assessed using a semi-quantitative system and a staining score was developed for the ECs of different vessel types in different areas of dermis at all grades. In biopsies from patients with SSc, superficial microvessel ECs showed a peak of eNOS expression in grade 1 skin which fell as the grade increased. By contrast, iNOS staining increased with the grade of skin lesion, a pattern paralleled by endothelial nitrotyrosine expression. From these findings, it is concluded that a metabolic switch occurs in dermal ECs from endothelial to cytokine inducible forms of NOS during the progression of the skin lesion of SSc. iNOS is a potent inducer of NO production which, in turn, can mediate NO free radical production. At a time of development of the SSc skin lesion when previous studies report evidence of EC damage, the cells express immunodetectable nitrotyrosine, a marker of NO-mediated free radical injury. The data suggest a role for iNOS-induced NO production in EC damage in SSc. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547586     DOI: 10.1002/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

Review 1.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

Review 2.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

3.  Attenuated nitric oxide bioavailability in systemic sclerosis: Evidence from the novel assessment of passive leg movement.

Authors:  Heather L Clifton; Daniel R Machin; H Jonathan Groot; Tracy M Frech; Anthony J Donato; Russell S Richardson; D Walter Wray
Journal:  Exp Physiol       Date:  2018-08-18       Impact factor: 2.969

4.  Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma.

Authors:  E J Kingdon; A R Mani; M T Frost; C P Denton; S H Powis; C M Black; K P Moore
Journal:  Ann Rheum Dis       Date:  2005-11-24       Impact factor: 19.103

Review 5.  The association between systemic sclerosis, arginine and asymmetric dimethylarginine.

Authors:  Li Zhang; Ya-Nan Wan; Jiu-Hua Zhao; Yu-Jie Wang; Ying-Xin Wang; Jun-Wei Yan; Xiao-Lei Huang; Jing Wang
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

6.  Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis.

Authors:  Zeling Cao; Stephen C Mathai; Laura K Hummers; Ami A Shah; Fredrick M Wigley; Noah Lechtzin; Paul M Hassoun; Reda E Girgis
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

7.  Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.

Authors:  Ivone Silva; Andreia Teixeira; José Oliveira; Isabel Almeida; Rui Almeida; Artur Águas; Carlos Vasconcelos
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

8.  Oncostatin M and its role in fibrosis.

Authors:  Lukasz Stawski; Maria Trojanowska
Journal:  Connect Tissue Res       Date:  2018-07-30       Impact factor: 3.417

9.  Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.

Authors:  Yoshihide Asano; Lukasz Stawski; Faye Hant; Kristin Highland; Richard Silver; Gabor Szalai; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

10.  Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features.

Authors:  K Takagi; Y Kawaguchi; M Hara; T Sugiura; M Harigai; N Kamatani
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.